[Improvement of parodontitis therapy of patients with HIV-infection].
For the purpose to determine the clinic-pathogenetic efficacy of cycloferon liniment in the combined therapy of periodontitis of patients with subclinical stage of HIV-infection medical examination and treatment of 40 patients was carried out. It was established that use of liniment cycloferon in the combined treatment of patients with subclinical stage of HIV-infection allowed to accelerate process of normalization of lipid peroxidation parameters and antioxidant potential of blood, to decrease infection load (herpes symplex virus I, Candida albicans, Staphylococcus aureus) in parodontal recess and evidence of local inflammation with reduction of activity of the tumours necrosis factor and interleukin 1beta, what provided acceleration of recuperation processes, lowering the frequency of parodontitis relapses.
Soboleva
L A
LA
Oseeva
A O
AO
Shul'diakov
A A
AA
Bulkina
N V
NV
D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D002176:Candida albicans / Q000302:isolation & purification; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D003587:Cytomegalovirus / Q000302:isolation & purification; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications*; D018259:Herpesvirus 1, Human / Q000302:isolation & purification; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008038:Liniments; D008297:Male; D010518:Periodontitis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D055815:Young Adult
D000166:Acridines; D007369:Interferon Inducers; D008038:Liniments; C026430:10-carboxymethyl-9-acridanone